Terms: = Head and neck cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Treatment
460 results:
1. Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations.
Groen-van Schooten TS; Harrasser M; Seidel J; Bos EN; Fleitas T; van Mourik M; Pouw RE; Goedegebuure RSA; Doeve BH; Sanders J; Bos J; van Berge Henegouwen MI; Thijssen VLJL; van Grieken NCT; van Laarhoven HWM; de Gruijl TD; Derks S
Front Immunol; 2024; 15():1372272. PubMed ID: 38638445
[TBL] [Abstract] [Full Text] [Related]
2. treatment of esophageal adenocarcinoma in patients with a history of bariatric surgery.
Nobel T; Sewell M; Boerner T; Bains MS; Bott MJ; Gerdes H; Gray K; Nishimura M; Park BJ; Shah P; Sihag S; Jones DR; Molena D
J Gastrointest Surg; 2024 Apr; 28(4):337-342. PubMed ID: 38583881
[TBL] [Abstract] [Full Text] [Related]
3. Investigating the causal role of the gut microbiota in esophageal cancer and its subtypes: a two-sample Mendelian randomization study.
Li J; Gao X; Sun X; Li H; Wei J; Lv L; Zhu L
BMC Cancer; 2024 Apr; 24(1):416. PubMed ID: 38575885
[TBL] [Abstract] [Full Text] [Related]
4. Risk of Esophageal Adenocarcinoma After Bariatric Surgery: A Meta-Analysis of Retrospective Studies.
Zhu C; Liu W; Hu D; Peng L
Obes Surg; 2024 May; 34(5):1726-1736. PubMed ID: 38536625
[TBL] [Abstract] [Full Text] [Related]
5. Management of high risk T1 esophageal adenocarcinoma following endoscopic resection.
Leclercq P; Bisschops R; Bergman JJGHM; Pouw RE
Best Pract Res Clin Gastroenterol; 2024 Feb; 68():101882. PubMed ID: 38522880
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of mutation landscapes of pretreatment versus recurrent squamous cell carcinoma of the oral cavity: The possible mechanism of resistance to standard treatment.
Payungwong T; Angkulkrerkkrai K; Chaiboonchoe A; Lausoontornsiri W; Jirawatnotai S; Chindavijak S
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2004. PubMed ID: 38477073
[TBL] [Abstract] [Full Text] [Related]
7. Metformin in Esophageal Carcinoma: Exploring Molecular Mechanisms and Therapeutic Insights.
Papadakos SP; Argyrou A; Lekakis V; Arvanitakis K; Kalisperati P; Stergiou IE; Konstantinidis I; Schizas D; Koufakis T; Germanidis G; Theocharis S
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474224
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis.
Pan L; Zhang Y; Gao Y; Qiu J
Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056
[TBL] [Abstract] [Full Text] [Related]
9. cyld induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma.
Li Y; Yang C; Xie L; Shi F; Tang M; Luo X; Liu N; Hu X; Zhu Y; Bode AM; Gao Q; Zhou J; Fan J; Li X; Cao Y
Cell Death Dis; 2024 Jan; 15(1):95. PubMed ID: 38287022
[TBL] [Abstract] [Full Text] [Related]
10. Advances in Screening for Barrett Esophagus and Esophageal Adenocarcinoma.
Vantanasiri K; Kamboj AK; Kisiel JB; Iyer PG
Mayo Clin Proc; 2024 Mar; 99(3):459-473. PubMed ID: 38276943
[TBL] [Abstract] [Full Text] [Related]
11. Malignant myoepithelioma of the external auditory canal - a rare case report with literature review and clinical importance of foramen of Huschke.
Mateášiková Z; Salzman R; Michálek J
World J Surg Oncol; 2024 Jan; 22(1):28. PubMed ID: 38268020
[TBL] [Abstract] [Full Text] [Related]
12. Clinical characteristics of intradermal nevus in the external auditory canal.
Kim YH
Medicine (Baltimore); 2024 Jan; 103(3):e36765. PubMed ID: 38241581
[TBL] [Abstract] [Full Text] [Related]
13. Clinical Significance and Prognostic Implications of Discontinuous Growth Pattern in Esophageal Adenocarcinoma: A Multi-Institutional Study.
Kmeid M; Lee G; Yang Z; Pacheco R; Lin J; Patil DT; Youssef M; Zhang Q; Alkashash AM; Li J; Lee H
Am J Surg Pathol; 2024 Apr; 48(4):447-457. PubMed ID: 38238961
[TBL] [Abstract] [Full Text] [Related]
14. Case report of radiotherapy combined with anlotinib and immunotherapy for a patient with esophageal cancer and esophageal fistula.
He L; Han Q; Zhao M; Ma H; Cheng P; Yang H; Zhao Y
Appl Radiat Isot; 2024 Mar; 205():111162. PubMed ID: 38142544
[TBL] [Abstract] [Full Text] [Related]
15. The association between histological subtypes and lymph node metastasis and prognosis in early esophageal cancer: a population-based study.
Lin JP; Chen XF; Zhou H; Zhuang FN; He H; Chen WJ; Wang F; Liu SY
Eur J Cancer Prev; 2024 Mar; 33(2):152-160. PubMed ID: 37991237
[TBL] [Abstract] [Full Text] [Related]
16. Incidence of Esophageal Adenocarcinoma, Mortality, and Esophagectomy in Barrett's Esophagus Patients Undergoing Endoscopic Eradication Therapy.
Smith ZL; Thorgerson AM; Dawson AZ; Wani S
Dig Dis Sci; 2023 Dec; 68(12):4439-4448. PubMed ID: 37863992
[TBL] [Abstract] [Full Text] [Related]
17. ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer.
Sindhoo A; Sipy S; Khan A; Selvaraj G; Alshammari A; Casida ME; Wei DQ
Database (Oxford); 2023 Oct; 2023():. PubMed ID: 37815872
[TBL] [Abstract] [Full Text] [Related]
18. Clinical Outcomes After Endoscopic Management of Low-Risk and High-Risk T1a Esophageal Adenocarcinoma: A Multicenter Study.
Kamboj AK; Goyal R; Vantanasiri K; Sachdeva K; Passe M; Lansing R; Garg N; Chandi PS; Ramirez FC; Kahn A; Fukami N; Wolfsen HC; Krishna M; Pai RK; Hagen C; Lee HE; Wang KK; Leggett CL; Iyer PG
Am J Gastroenterol; 2024 Apr; 119(4):662-670. PubMed ID: 37795907
[TBL] [Abstract] [Full Text] [Related]
19. Atrial Flutter After Radiofrequency Ablation for Barrett's Esophagus: A Case Report.
Fassari A; De Blasi V; Basile M; Perretta S
Am J Case Rep; 2023 Oct; 24():e941264. PubMed ID: 37794654
[TBL] [Abstract] [Full Text] [Related]
20. [Barrett's esophagus: Diagnosis, treatment and minimizing of risk].
Thorell A; Bednarska O; Jeremiasen M; Mottacki N; Lundell L
Lakartidningen; 2023 Sep; 120():. PubMed ID: 37746770
[TBL] [Abstract] [Full Text] [Related]
[Next]
